EUVIMEDEUVIMED entdecken
Crossref

SENP3 Deficiency Inhibits Atherosclerosis by Regulating TLR4/NF‐κB and SOAT2

Zhenyu Zhou, Tian Jiang, Xiao Tang, Hanfei Tang, Tonglei Han, Jianmin Gu, Shaoyuan Zhang, Changhao Ren, Zhenyu Shi iD, Weiguo Fu, Fen Yu, Minhui Li und 3 weitere

The FASEB Journal · 15.07.2026 · 40 (13)

DOI: 10.1096/fj.202502298r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 29.06.2026. Verfasst von Zhenyu Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Atherosclerosis, Cysteine Endopeptidases, Toll-Like Receptor 4, NF-kappa B. Die Arbeit nennt 77 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SUMOylation plays critical roles in both initiation and development of atherosclerosis. SUMO‐specific protease 3 (SENP3), a SUMO‐specific protease that targets SUMO2/3 for deSUMOylation, is involved in vascular remodeling and the modulation of macrophage functions. Here, we probed for the role of SENP3 in macrophages in the development of atherosclerosis. Stable and unstable plaques were collected from patients with atherosclerosis. A macrophage‐specific SENP3 knockout mouse ( Senp3 Mac‐KO ) was generated and performed for a murine atherosclerosis model. Transcriptional sequencing was performed to identify potential mechanisms. SENP3 expression in macrophages was increased in unstable plaques, compared to stable plaques. The mean fluorescence intensity of SENP3 in macrophages infiltrating carotid plaques was positively correlated with circulating pro‐inflammatory cytokines, low density lipoprotein (LDL‐C), and triglycerides in atherosclerosis patients. Senp3 Mac‐KO mice exhibited a markedly reduced atherosclerotic plaque area in the aorta, compared to wild‐type mice. Knockdown of SENP3 in macrophages resulted in decreased secretion of pro‐inflammatory cytokines, increased secretion of anti‐inflammatory factors, and reduced foam cell formation. Transcriptional analysis identified significant enrichment in Toll‐like receptor (TLR4) signaling pathway modulated by SENP3. Genetic deletion of either TLR4 ( Tlr4 −/− ) or Sterol O‐Acyltransferase 2 (SOAT2) ( Soat2 −/− ) attenuated the exacerbation of atherosclerosis development induced by SENP3 overexpression. Furthermore, SENP3 regulated TLR4 and SOAT2 expression indirectly via the transcription factor MYC rather than through direct deSUMOylation of TLR4 or SOAT2 themselves. Downregulation of SENP3 in macrophages suppresses pro‐inflammatory cytokine release by inhibiting TLR4 signaling and reduces foam cell formation by impeding SOAT2 expression, both mediated by the transcription factor MYC, thereby attenuating the development of atherosclerosis. Hence, SENP3 may represent a potential therapeutic target in atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisCysteine EndopeptidasesToll-Like Receptor 4NF-kappa BAnimalsMiceMice, KnockoutHumansMacrophagesMice, Inbred C57BLSignal TransductionMale

Stichwörter der Autor:innen

SENP3atherosclerosisfoam cellsinflammationmacrophages

Substanzen

Cysteine EndopeptidasesToll-Like Receptor 4NF-kappa BSenp3 protein, mouseTlr4 protein, mouseSENP3 protein, human

Autor:innen und Institutionen

  • Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Institute of Vascular Surgery, Fudan University, Shanghai, China.
  • National Clinical Research Center for Interventional Medicine, Shanghai, China.
  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Lung Inflammation and Injury, Shanghai, China.

ORCID-Profile: Zhenyu Shi, Daqiao Guo

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, Z., Jiang, T., Tang, X., Tang, H., Han, T., Gu, J., Zhang, S., Ren, C., Shi, Z., Fu, W., Yu, F., Li, M., Lin, C., Tai, Z., & Guo, D. (2026). SENP3 Deficiency Inhibits Atherosclerosis by Regulating TLR4/NF‐κB and SOAT2. The FASEB Journal, 40(13). https://doi.org/10.1096/fj.202502298r

Vancouver

Zhou Z, Jiang T, Tang X, Tang H, Han T, Gu J, et al. SENP3 Deficiency Inhibits Atherosclerosis by Regulating TLR4/NF‐κB and SOAT2. The FASEB Journal. 2026;40(13). doi:10.1096/fj.202502298r

BibTeX
@article{Zhou2026,
  author = {Zhou, Zhenyu and Jiang, Tian and Tang, Xiao and Tang, Hanfei and Han, Tonglei and Gu, Jianmin and Zhang, Shaoyuan and Ren, Changhao and Shi, Zhenyu and Fu, Weiguo and Yu, Fen and Li, Minhui and Lin, Changpo and Tai, Zongguang and Guo, Daqiao},
  title = {SENP3 Deficiency Inhibits Atherosclerosis by Regulating TLR4/NF‐κB and SOAT2},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {13},
  doi = {10.1096/fj.202502298r}
}
Kostenlos starten →